[HTML][HTML] Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause
SD Sullivan, PM Sarrel, LM Nelson - Fertility and sterility, 2016 - Elsevier
Primary ovarian insufficiency (POI) is a rare but important cause of ovarian hormone
deficiency and infertility in women. In addition to causing infertility, POI is associated with …
deficiency and infertility in women. In addition to causing infertility, POI is associated with …
The roles of androgens in humans: biology, metabolic regulation and health
M Alemany - International journal of molecular sciences, 2022 - mdpi.com
Androgens are an important and diverse group of steroid hormone molecular species. They
play varied functional roles, such as the control of metabolic energy fate and partition, the …
play varied functional roles, such as the control of metabolic energy fate and partition, the …
Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline
KA Martin, RR Anderson, RJ Chang… - The Journal of …, 2018 - academic.oup.com
Abstract Objective To update the “Evaluation and Treatment of Hirsutism in Premenopausal
Women: An Endocrine Society Clinical Practice Guideline,” published by the Endocrine …
Women: An Endocrine Society Clinical Practice Guideline,” published by the Endocrine …
Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline
Objective: To update practice guidelines for the therapeutic use of androgens in women.
Participants: A Task Force appointed by the Endocrine Society, American Congress of …
Participants: A Task Force appointed by the Endocrine Society, American Congress of …
The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis
Y Zimmerman, MJC Eijkemans… - Human reproduction …, 2014 - academic.oup.com
BACKGROUND Combined oral contraceptives (COCs) reduce levels of androgen,
especially testosterone (T), by inhibiting ovarian and adrenal androgen synthesis and by …
especially testosterone (T), by inhibiting ovarian and adrenal androgen synthesis and by …
Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement
W Rosner, RJ Auchus, R Azziz… - The Journal of Clinical …, 2007 - academic.oup.com
Objective: The objective of the study was to evaluate the current state of clinical assays for
total and free testosterone. Participants: The five participants were appointed by the Council …
total and free testosterone. Participants: The five participants were appointed by the Council …
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause
WA Rocca, JH Bower, DM Maraganore, JE Ahlskog… - Neurology, 2007 - AAN Enterprises
Objective: There is increasing laboratory evidence for a neuroprotective effect of estrogen;
however, the clinical and epidemiologic evidence remains limited and conflicting. We …
however, the clinical and epidemiologic evidence remains limited and conflicting. We …
The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed?
S Khosla, LJ Melton III, BL Riggs - Journal of bone and mineral …, 2011 - academic.oup.com
Over a decade ago, we proposed a “unitary” model for the pathogenesis of osteoporosis that
identified estrogen deficiency as the predominant cause of both the early, accelerated, and …
identified estrogen deficiency as the predominant cause of both the early, accelerated, and …
Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline
KA Martin, RJ Chang, DA Ehrmann… - The Journal of …, 2008 - academic.oup.com
Objective: Our objective was to develop clinical practice guidelines for the evaluation and
treatment of hirsutism in premenopausal women. Participants: The Task Force was …
treatment of hirsutism in premenopausal women. Participants: The Task Force was …
[HTML][HTML] Testosterone for low libido in postmenopausal women not taking estrogen
SR Davis, M Moreau, R Kroll, C Bouchard… - … England Journal of …, 2008 - Mass Medical Soc
Background The efficacy and safety of testosterone treatment for hypoactive sexual desire
disorder in postmenopausal women not receiving estrogen therapy are unknown. Methods …
disorder in postmenopausal women not receiving estrogen therapy are unknown. Methods …